Апокалипсис 2035

Recommend Documents

The TIM-3-Next Generation Immunotherapy market is expected to generate USD 1,218 Million in the year 2035. The key players in TIM-3-Next Generation Immunotherapy market include Symphogen, GlaxoSmithKline, Novartis, Bristol-Myers Squibb, Ono Pharma

According to DelveInsight, the LAG-3-Next Generation Immunotherapy market is expected to generate USD 3,421 Million in the year 2035 with a significant CAGR in the forecast period. NSCLC will occupy the major market share that is 98.81% by 2035. Laun

Lecture Notes in Mathematics Editors: J.-M. Morel, Cachan B. Teissier, Paris Editors Mathematical Biosciences Subseries...